Statistics
Publications
16
Citations
536
H-Index
14
Active since
2000
Gregory Locke is an author at Bristol-Myers Squibb (United States) specializing in life sciences, enzyme inhibition, and pharmacology.
Publications per year
2000–2023
16
16
Enhanced antitumor immunity by a novel small molecule HPK1 inhibitor
Dan You, Stephen Hillerman, Gregory Locke et al. · Journal for ImmunoTherapy of Cancer · 2021 · 76 citations · Full text
Medicine, Immunology, Pharmacology +17
Aiying Wang, Charles R. Dorso, Lisa M. Kopcho et al. · BMC Pharmacology · 2012 · 60 citations · Full text
1–5 of 16